Literature DB >> 19241156

Comparative analysis and clinical value of the expression of metalloproteases and their inhibitors by intratumor stromal fibroblasts and those at the invasive front of breast carcinomas.

J M Del Casar1, L O González, E Alvarez, S Junquera, L Marín, L González, M Bongera, J Vázquez, F J Vizoso.   

Abstract

An immunohistochemical study was performed using tissue arrays and specific antibodies against MMPs -1, -2, -7, -9, -11, -13, -14, and TIMPs -1, -2 and -3. More than 5,000 determinations on cancer specimens from 124 patients with invasive breast cancer were performed at the center of the tumor and the invasive front. Immunostaining for MMPs/TIMPs by fibroblasts was evaluated. To identify specific groups of tumors with distinct expression profiles, the data obtained from both fibroblast populations were analyzed by unsupervised hierarchical cluster analysis. Intratumor stromal fibroblasts more frequently showed expression of MMP-2, -7, and -14, and TIMP-3, but less frequently of MMP-9 than fibroblasts at the invasive front. Multivariate analysis showed that a high profile of MMPs and TIMPs staining in both fibroblast populations was the most potent predictor factor of distant metastases, whereas a low staining profile in fibroblasts was associated with a low risk of metastases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19241156     DOI: 10.1007/s10549-009-0351-z

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  18 in total

1.  A phenotype from tumor stroma based on the expression of metalloproteases and their inhibitors, associated with prognosis in breast cancer.

Authors:  Noemí Eiró; Belen Fernandez-Garcia; Julio Vázquez; José M Del Casar; Luis O González; Francisco J Vizoso
Journal:  Oncoimmunology       Date:  2015-01-29       Impact factor: 8.110

2.  Low microvascular density at the tumor center is related to the expression of metalloproteases and their inhibitors and with the occurrence of distant metastasis in breast carcinomas.

Authors:  Oscar Fernández-Guinea; Almudena Álvarez-Cofiño; Noemí Eiró; Luis O González; José M del Casar; Belen Fernandez-Garcia; Maria L Lamelas; Alejandro Andicoechea; Francisco J Vizoso
Journal:  Int J Clin Oncol       Date:  2012-06-12       Impact factor: 3.402

3.  Collagenase-3 expression by tumor cells and gelatinase B expression by stromal fibroblast-like cells are associated with biochemical recurrence after radical prostatectomy in patients with prostate cancer.

Authors:  Safwan Escaff; Jesús M Fernández; Luis O González; Aurelio Suárez; Salomé González-Reyes; José M González; Francisco J Vizoso
Journal:  World J Urol       Date:  2010-10-01       Impact factor: 4.226

4.  Comparative study of the expression of metalloproteases and their inhibitors in different localizations within primary tumours and in metastatic lymph nodes of breast cancer.

Authors:  María Fernanda García; Salomé González-Reyes; Luis Ovidio González; Sara Junquera; Nana Berdize; José Manuel Del Casar; María Medina; Francisco José Vizoso
Journal:  Int J Exp Pathol       Date:  2010-04-20       Impact factor: 1.925

Review 5.  Perioperative propofol-paravertebral anesthesia decreases the metastasis and progression of breast cancer.

Authors:  Xiu Chen; Peng Lu; Lin Chen; Su-jin Yang; Hong-Yu Shen; Dan-dan Yu; Xiao-hui Zhang; Shan-liang Zhong; Jian-hua Zhao; Jin-hai Tang
Journal:  Tumour Biol       Date:  2015-09-17

Review 6.  Matrix metalloproteinase-induced epithelial-mesenchymal transition in breast cancer.

Authors:  Evette S Radisky; Derek C Radisky
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-05-05       Impact factor: 2.673

Review 7.  Matrix metalloproteinases in cancer: their value as diagnostic and prognostic markers and therapeutic targets.

Authors:  Elin Hadler-Olsen; Jan-Olof Winberg; Lars Uhlin-Hansen
Journal:  Tumour Biol       Date:  2013-05-17

Review 8.  Breast cancer-associated fibroblasts: their roles in tumor initiation, progression and clinical applications.

Authors:  Aixiu Qiao; Feng Gu; Xiaojing Guo; Xinmin Zhang; Li Fu
Journal:  Front Med       Date:  2016-01-20       Impact factor: 4.592

Review 9.  Matrix metalloproteinases as breast cancer drivers and therapeutic targets.

Authors:  Evette S Radisky; Derek C Radisky
Journal:  Front Biosci (Landmark Ed)       Date:  2015-06-01

10.  Impact of CD68/(CD3+CD20) ratio at the invasive front of primary tumors on distant metastasis development in breast cancer.

Authors:  Noemí Eiró; Iván Pidal; Belen Fernandez-Garcia; Sara Junquera; Maria L Lamelas; José M del Casar; Luis O González; Alfonso López-Muñiz; Francisco J Vizoso
Journal:  PLoS One       Date:  2012-12-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.